I saw that news last night hottod although i'm not sure if PYC really plays in that field, it looks more aimed at bio's with vaccines currently in clinical trials I'm guessing ASX stocks like AHZ,BDM,BIT, might be a better shot, the move by Gates is basically looking to provide funding so they can inturn take those candidates into Africa free of charge while not infringing on the companies ownership in the major markets - i'm also assuming he's looking to take promising drugs that are not yet approved into Africa ? As PYC is all pre-clinical might be a little to early, the technology itself is probably of little use to the Gates Foundation until there's been a compound that is atleast at some point in human trials. Always open to suprises though :-)
PYC Price at posting:
4.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)